Pluri Inc. (NASDAQ:PLUR) Short Interest Up 273.9% in October

Pluri Inc. (NASDAQ:PLUR) saw a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 8,600 shares, an increase of 273.9% from the October 15th total of 2,300 shares. Currently, 0.2% of the company’s stock are short sold. Based on an average daily trading volume, of 16,000 shares, the short-interest ratio is currently 0.5 days.

Pluri Stock Up 9.2 %

Shares of Pluri stock traded up $0.51 during trading hours on Wednesday, hitting $6.04. 53,177 shares of the company’s stock traded hands, compared to its average volume of 17,612. Pluri has a twelve month low of $3.77 and a twelve month high of $8.48. The company has a market cap of $33.04 million, a PE ratio of -1.00 and a beta of 1.62. The company has a quick ratio of 6.98, a current ratio of 6.98 and a debt-to-equity ratio of 4.44. The stock has a 50 day simple moving average of $5.08 and a 200-day simple moving average of $5.44.

Pluri (NASDAQ:PLUR) last released its earnings results on Wednesday, September 18th. The company reported ($2.98) earnings per share for the quarter. Pluri had a negative return on equity of 684.77% and a negative net margin of 4,184.28%. The company had revenue of $0.26 million during the quarter.

About Pluri

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.